SEK 274.3
(0.94%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 615.06 Million SEK | 0.72% |
2022 | 538.55 Million SEK | 20.14% |
2021 | 445.08 Million SEK | 10.91% |
2020 | 397.13 Million SEK | 14.27% |
2019 | 349.56 Million SEK | 26.86% |
2018 | 255.06 Million SEK | -2.96% |
2017 | 232.61 Million SEK | 12.42% |
2016 | 241.52 Million SEK | 31.04% |
2015 | 207.65 Million SEK | -0.23% |
2014 | 193.6 Million SEK | -0.8% |
2013 | 188.44 Million SEK | 57.93% |
2012 | 133.76 Million SEK | -23.25% |
2011 | 172.63 Million SEK | 132.06% |
2010 | 56.3 Million SEK | -11.65% |
2009 | 75.16 Million SEK | -28.74% |
2008 | 110.53 Million SEK | 4.37% |
2007 | 103.4 Million SEK | -17.46% |
2006 | 91.95 Million SEK | 19.57% |
2005 | 103.64 Million SEK | 4.87% |
2004 | 100.9 Million SEK | -7.55% |
2003 | 118.63 Million SEK | 24.84% |
2002 | 95.02 Million SEK | 30.44% |
2001 | 72.84 Million SEK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 112.23 Million SEK | -49.38% |
2023 Q4 | 217.29 Million SEK | 146.94% |
2023 Q3 | 87.99 Million SEK | -56.08% |
2023 Q1 | 93.85 Million SEK | -61.98% |
2023 FY | - SEK | 0.72% |
2023 Q2 | 200.36 Million SEK | 113.49% |
2022 Q1 | 86.55 Million SEK | -50.71% |
2022 Q3 | 110.29 Million SEK | -14.94% |
2022 FY | - SEK | 20.14% |
2022 Q2 | 129.67 Million SEK | 49.81% |
2022 Q4 | 246.86 Million SEK | 123.81% |
2021 Q4 | 175.61 Million SEK | 95.68% |
2021 Q1 | 109.18 Million SEK | -41.53% |
2021 FY | - SEK | 10.91% |
2021 Q2 | 102.73 Million SEK | -5.9% |
2021 Q3 | 89.74 Million SEK | -12.65% |
2020 Q2 | 109.04 Million SEK | 140.35% |
2020 Q1 | 45.37 Million SEK | -71.98% |
2020 Q3 | 89.19 Million SEK | -18.21% |
2020 Q4 | 186.71 Million SEK | 109.34% |
2020 FY | - SEK | 14.27% |
2019 FY | - SEK | 26.86% |
2019 Q1 | 46.3 Million SEK | -53.54% |
2019 Q2 | 60.02 Million SEK | 29.63% |
2019 Q3 | 108.36 Million SEK | 80.54% |
2019 Q4 | 161.89 Million SEK | 49.39% |
2018 Q1 | 63.08 Million SEK | -38.68% |
2018 FY | - SEK | -2.96% |
2018 Q4 | 99.66 Million SEK | 37.68% |
2018 Q3 | 72.39 Million SEK | 11.14% |
2018 Q2 | 65.13 Million SEK | 3.25% |
2017 Q3 | 68.05 Million SEK | -9.13% |
2017 Q4 | 102.87 Million SEK | 51.18% |
2017 Q1 | 59.05 Million SEK | -42.63% |
2017 Q2 | 74.89 Million SEK | 26.81% |
2017 FY | - SEK | 12.42% |
2016 Q1 | 46.51 Million SEK | -26.54% |
2016 Q3 | 49.54 Million SEK | -18.51% |
2016 Q4 | 102.93 Million SEK | 107.75% |
2016 Q2 | 60.79 Million SEK | 30.7% |
2016 FY | - SEK | 31.04% |
2015 Q1 | 41.15 Million SEK | -38.8% |
2015 FY | - SEK | -0.23% |
2015 Q4 | 63.32 Million SEK | 9.75% |
2015 Q2 | 45.47 Million SEK | 10.48% |
2015 Q3 | 57.69 Million SEK | 26.88% |
2014 FY | - SEK | -0.8% |
2014 Q1 | 52.64 Million SEK | -34.47% |
2014 Q2 | 46.42 Million SEK | -11.83% |
2014 Q4 | 67.25 Million SEK | 60.88% |
2014 Q3 | 41.8 Million SEK | -9.94% |
2013 Q4 | 80.34 Million SEK | 88.87% |
2013 Q3 | 42.53 Million SEK | 1.68% |
2013 Q1 | 23.72 Million SEK | -53.14% |
2013 Q2 | 41.83 Million SEK | 76.37% |
2013 FY | - SEK | 57.93% |
2012 Q2 | 34.03 Million SEK | 120.47% |
2012 Q1 | 15.43 Million SEK | -81.68% |
2012 FY | - SEK | -23.25% |
2012 Q4 | 50.62 Million SEK | 50.38% |
2012 Q3 | 33.66 Million SEK | -1.1% |
2011 Q2 | 55.45 Million SEK | 232.76% |
2011 Q3 | 16.22 Million SEK | -70.74% |
2011 Q4 | 84.28 Million SEK | 419.46% |
2011 FY | - SEK | 132.06% |
2011 Q1 | 16.66 Million SEK | -37.25% |
2010 Q1 | 14.24 Million SEK | -57.63% |
2010 Q3 | 10.29 Million SEK | -56.19% |
2010 FY | - SEK | -11.65% |
2010 Q4 | 26.55 Million SEK | 158.05% |
2010 Q2 | 23.49 Million SEK | 64.98% |
2009 Q4 | 33.61 Million SEK | 191.25% |
2009 FY | - SEK | -28.74% |
2009 Q1 | 20.3 Million SEK | 0.0% |
2009 Q2 | 18.97 Million SEK | -6.55% |
2009 Q3 | 11.54 Million SEK | -39.17% |
2008 FY | - SEK | 4.37% |
2007 FY | - SEK | -17.46% |
2006 FY | - SEK | 19.57% |
2005 FY | - SEK | 4.87% |
2004 FY | - SEK | -7.55% |
2003 FY | - SEK | 24.84% |
2002 FY | - SEK | 30.44% |
2001 FY | - SEK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acarix AB (publ) | -77.12 Million SEK | 897.516% |
ADDvise Group AB (publ) | 411.9 Million SEK | -49.323% |
ADDvise Group AB (publ) | 411.9 Million SEK | -49.323% |
Arcoma AB | 6.24 Million SEK | -9744.11% |
Bactiguard Holding AB (publ) | -89.98 Million SEK | 783.537% |
BICO Group AB (publ) | 322.3 Million SEK | -90.835% |
Boule Diagnostics AB (publ) | 65.97 Million SEK | -832.206% |
CellaVision AB (publ) | 207.24 Million SEK | -196.779% |
Clinical Laserthermia Systems AB (publ) | -68.4 Million SEK | 999.132% |
Chordate Medical Holding AB (publ) | -27.94 Million SEK | 2301.124% |
C-Rad AB (publ) | 48.9 Million SEK | -1157.689% |
Duearity AB (publ) | -24.77 Million SEK | 2582.182% |
Dignitana AB (publ) | -264 Thousand SEK | 233077.273% |
Episurf Medical AB (publ) | -87.7 Million SEK | 801.323% |
Getinge AB (publ) | 5.92 Billion SEK | 89.626% |
Scandinavian Real Heart AB (Publ) | -67.25 Million SEK | 1014.587% |
Iconovo AB (publ) | -35.33 Million SEK | 1840.631% |
Integrum AB (publ) | 8.76 Million SEK | -6920.008% |
Luxbright AB (publ) | -23.86 Million SEK | 2677.06% |
Mentice AB (publ) | 28.87 Million SEK | -2030.225% |
OssDsign AB (publ) | -122.02 Million SEK | 604.061% |
Paxman AB (publ) | 31.22 Million SEK | -1869.516% |
Promimic AB (publ) | -3.68 Million SEK | 16795.444% |
Qlife Holding AB (publ) | -150.5 Million SEK | 508.664% |
SciBase Holding AB (publ) | -51.82 Million SEK | 1286.71% |
ScandiDos AB (publ) | -13.35 Million SEK | 4705.121% |
Sedana Medical AB (publ) | -51.67 Million SEK | 1290.27% |
Senzime AB (publ) | -118.82 Million SEK | 617.627% |
SpectraCure AB (publ) | -20.96 Million SEK | 3033.187% |
Stille AB | 56.04 Million SEK | -997.518% |
Vitrolife AB (publ) | -3.18 Billion SEK | 119.311% |
Xvivo Perfusion AB (publ) | 126.57 Million SEK | -385.929% |